Monoclonal antibodies for cartillage oligomeric matrix protein
US8110663B2 · kind B2 · utility
Assignee
Inventor
Key dates
| Filing date | Apr 27, 2010 |
| Grant date | Feb 7, 2012 |
| Priority date | — |
| Expiry date | Apr 27, 2030 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N33/6887
- WIPO fieldMeasurement
- WIPO sectorInstruments
Abstract
The present invention provides a new sensitive direct sandwich assay for determining the presence of COMP in a clinical sample. Two monoclonal antibodies directed against separate antigenic determinants of the COMP molecules are used in the assay. The invention also relates to three particularly advantageous monoclonal antibodies per se that are directed against human COMP. Cell cultures manufacturing these antibodies have been deposited according to the Budapest Treaty at Deutsche Sammlung von Mikroorganismen and Zellkulturen GmbH, and have been assigned accesion numbers DSM ACC2406, DSM ACC2408 and DSM ACC2418, respectively. A diagnostic kit comprising at least two of these monoclonal antibodies also constitute a part of the present invention.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.